Article Information
History
- February 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- V Borges1,*,
- J Isidro1,*,
- NS Trovão2,*,
- S Duarte3,
- H Cortes-Martins4,
- H Martiniano3,
- I Gordo5,
- R Leite5,
- L Vieira3,7,
- Portuguese network for SARS-CoV-2 genomics (Consortium)8,
- R Guiomar9 and
- JP Gomes1,#
- 1Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge (INSA), Portugal
- 2Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA
- 3Innovation and Technology Unit, Department of Human Genetics; National Institute of Health Dr. Ricardo Jorge (INSA), Portugal
- 4Reference and Surveillance Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal
- 5Instituto Gulbenkian de Ciência (IGC), Oeiras, Portugal
- 7Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, Nova Medical School; Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
- 8Portuguese network for SARS-CoV-2 genomics (Consortium). The full list of authors and affiliations is provided as Supplementary Material
- 9National Reference Laboratory for Influenza and other Respiratory Viruses, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal
- ↵#Correspondence:
João Paulo Gomes, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Av. Padre Cruz, 1649-016 Lisbon, Portugal. Tel.: (+351) 217 519 241; fax: (+351) 217 526 400., E-mail:
j.paulo.gomes{at}insa.min-saude.pt
↵* Contributed equally